132: Research Strategies of Memphis — Memphis, Tennessee

132: Research Strategies of Memphis is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

132: Research Strategies of Memphis has participated in 1 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder.

Sponsors: Arbor Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Memphis

Browse all research sites in Tennessee · View every site in Memphis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 132: Research Strategies of Memphis?

132: Research Strategies of Memphis has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 132: Research Strategies of Memphis conducted?

132: Research Strategies of Memphis has 1 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder.

Is 132: Research Strategies of Memphis accredited by Crixeo Clinical Trials?

132: Research Strategies of Memphis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 132: Research Strategies of Memphis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.